50 related articles for article (PubMed ID: 1688311)
1. The influence of agonists and antagonists of dopaminergic system on the formation of audiogenic seizures in rats during the ethanol abstinence period.
Kaliszuk S; Borzecki Z; Swies Z
Ann Univ Mariae Curie Sklodowska Med; 1990; 45():163-7. PubMed ID: 1688311
[TBL] [Abstract][Full Text] [Related]
2. [The role of dopamine neurotransmission on the development of ethanol dependence and course of abstinence syndrome].
Samochowiec J
Ann Acad Med Stetin; 1994; 40():195-217. PubMed ID: 7503446
[TBL] [Abstract][Full Text] [Related]
3. Effects of 6-hydroxydopamine-induced lesions of A10 dopaminergic neurons and neuroleptic or bromocriptine treatment on ethanol withdrawal syndrome in rats.
Trzaskowska E; Puciłowski O; Kostowski W; Bidziński A
Pol J Pharmacol Pharm; 1983; 35(5):339-49. PubMed ID: 6141554
[TBL] [Abstract][Full Text] [Related]
4. The influence of bromocriptine on sexual activity in ethanol-exposed male rats.
Kaliszuk S; Borzecki Z; Swies Z
Ann Univ Mariae Curie Sklodowska Med; 1989; 44():109-14. PubMed ID: 2562677
[TBL] [Abstract][Full Text] [Related]
5. The role of dopamine neurotransmission in ethanol dependence development and ethanol withdrawal in rats.
Samochowiec J; Kleinrok Z; Horodnicki J
Pharmazie; 1995 Dec; 50(12):815-8. PubMed ID: 8584559
[TBL] [Abstract][Full Text] [Related]
6. Involvement of opioid and other systems in ethanol abstinence audiogenic seizures in the rat?
Kotlińska J; Langwiński R
Pol J Pharmacol Pharm; 1985; 37(2):103-11. PubMed ID: 2995952
[TBL] [Abstract][Full Text] [Related]
7. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
Capasso A; Sorrentino L
Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
[TBL] [Abstract][Full Text] [Related]
8. Effects of bromocriptine and haloperidol on ethanol withdrawal syndrome in rats.
Uzbay IT; Akarsu ES; Kayaalp SO
Pharmacol Biochem Behav; 1994 Dec; 49(4):969-74. PubMed ID: 7886115
[TBL] [Abstract][Full Text] [Related]
9. Effects of dopaminergic agonists and antagonists on the serum prolactin levels in alcoholized rats.
Samochowiec J; Kleinrok Z; Jagiełło-Wójtowicz E; Horodnicki J; Rommelspacher H; Schmidt LG
Pol J Pharmacol; 1997 Aug; 49(4):221-7. PubMed ID: 9437765
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacological analysis of the participation of the catecholaminergic system in the development of the abstinence syndrome in rats].
Varkov AI
Farmakol Toksikol; 1985; 48(6):11-3. PubMed ID: 3002844
[TBL] [Abstract][Full Text] [Related]
11. [Prolactin in the alcohol withdrawal syndrome. Role of the dopaminergic system].
Nardoni A; Marchetti E; Geatti O; Di Piazza V; Rossi G
Minerva Med; 1984 Dec; 75(47-48):2833-8. PubMed ID: 6521953
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms for metoclopramide-mediated sensitization and haloperidol-induced catalepsy in rats.
Agovic MS; Yablonsky-Alter E; Lidsky TI; Banerjee SP
Eur J Pharmacol; 2008 Jun; 587(1-3):181-6. PubMed ID: 18457824
[TBL] [Abstract][Full Text] [Related]
13. Effect of acetyl-L-carnitine on ethanol consumption and alcohol abstinence syndrome in rats.
Mangano NG; Clementi G; Costantino G; Calvani M; Matera M
Drugs Exp Clin Res; 2000; 26(1):7-12. PubMed ID: 10761531
[TBL] [Abstract][Full Text] [Related]
14. Selective c-fos induction and decreased dopamine release in the central nucleus of amygdala in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome.
Panagis G; Hildebrand BE; Svensson TH; Nomikos GG
Synapse; 2000 Jan; 35(1):15-25. PubMed ID: 10579804
[TBL] [Abstract][Full Text] [Related]
15. Dopaminergic system does not play a major role in the precipitated cannabinoid withdrawal syndrome.
Sañudo-Peña MC; Force M; Tsou K; McLemore G; Roberts L; Walker JM
Zhongguo Yao Li Xue Bao; 1999 Dec; 20(12):1121-4. PubMed ID: 11216447
[TBL] [Abstract][Full Text] [Related]
16. Chronic treatment with atypical neuroleptics sulpiride and metoclopramide increases striatal enkephalins in rat brain.
Herman ZS; Huzarska M
Pol J Pharmacol; 1993; 45(5-6):493-502. PubMed ID: 8012472
[TBL] [Abstract][Full Text] [Related]
17. Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity.
Obuchowicz E; Krysiak R; Wieronska JM; Smialowska M; Herman ZS
Neuropeptides; 2005 Oct; 39(5):515-23. PubMed ID: 16154634
[TBL] [Abstract][Full Text] [Related]
18. Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor.
Valdez GR; Roberts AJ; Chan K; Davis H; Brennan M; Zorrilla EP; Koob GF
Alcohol Clin Exp Res; 2002 Oct; 26(10):1494-501. PubMed ID: 12394282
[TBL] [Abstract][Full Text] [Related]
19. Monosialoganglioside (GM1) attenuates the behavioural effects of long-term haloperidol administration in supersensitive rats.
Perry JC; Vital MA; Frussa-Filho R; Tufik S; Palermo-Neto J
Eur Neuropsychopharmacol; 2004 Mar; 14(2):127-33. PubMed ID: 15013028
[TBL] [Abstract][Full Text] [Related]
20. Impairment of dopaminergic system function after chronic treatment with corticotropin-releasing factor.
Izzo E; Sanna PP; Koob GF
Pharmacol Biochem Behav; 2005 Aug; 81(4):701-8. PubMed ID: 16005056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
